Junaid Raja
Impact in
-
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
-
- Virus-based gene therapy research
Papers in
-
- Renal cell carcinoma treatment 2
- Surgery 5
- Vascular anomalies and interventions 3
- Co-authors
- Hyun S. Kim (4 shared papers)Johannes Ludwig (2 shared papers)Scott Gettinger (2 shared papers)Kurt A. Schalper (1 shared paper)Amir M. Mohareb (1 shared paper)Adebowale Adeniran (1 shared paper)Junjian Huang (7 shared papers)Mahan Mathur (1 shared paper)
- Journals
- Journal for ImmunoTherapy of Cancer (2 papers)World Medical & Health Policy (1 paper)Journal of Infection and Public Health (1 paper)Thrombosis Research (1 paper)Abdominal Radiology (1 paper)
- Partner nations
- United StatesGermanySouth Korea
In The Last Decade
Junaid Raja
12 papers receiving 291 citations
Junaid Raja's Hit Papers
Peers
Comparison fields: 5 of 49
- Oncology 153
- Genetics 146
- Biotechnology 30
- Immunology 67
- Infectious Diseases 27
Countries citing papers authored by Junaid Raja
This map shows the geographic impact of Junaid Raja's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junaid Raja with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junaid Raja more than expected).
Fields of papers citing papers by Junaid Raja
This network shows the impact of papers produced by Junaid Raja. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junaid Raja. The network helps show where Junaid Raja may publish in the future.
Co-authors
The 25 scholars most cited alongside Junaid Raja, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Oncolytic virus immunotherapy: future prospects for oncology Hit paper breakdown → | 2018 | 252 |
| 2 | 2018 | 16 | |
| 3 | 2016 | 8 | |
| 4 | 2017 | 4 | |
| 5 | 2014 | 3 | |
| 6 | 2024 | 2 | |
| 7 | 2019 | 2 | |
| 8 | 2024 | 2 | |
| 9 | 2021 | 2 | |
| 10 | 2014 | 2 | |
| 11 | 2024 | 1 | |
| 12 | 2017 | 1 | |
| 13 | 2023 | 0 | |
| 14 | 2019 | 0 | |
| 15 | 2024 | 0 | |
| 16 | 2019 | 0 | |
| 17 | 2013 | 0 | |
| 18 | 2024 | 0 | |
| 19 | 2025 | 0 | |
| 20 | 2023 | 0 |
About Junaid Raja
Junaid Raja is a scholar working on Pulmonary and Respiratory Medicine, Surgery, Oncology, Emergency Medical Services and Critical Care and Intensive Care Medicine, having authored 21 papers that have together received 295 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (4 papers), Vascular anomalies and interventions (3 papers), Renal cell carcinoma treatment (2 papers), Central Venous Catheters and Hemodialysis (2 papers), Radiation Dose and Imaging (2 papers), Ultrasound in Clinical Applications (2 papers), Airway Management and Intubation Techniques (2 papers) and Venous Thromboembolism Diagnosis and Management (1 paper). The work is most often cited by research in Oncology (153 citations), Genetics (146 citations), Biotechnology (30 citations), Immunology (67 citations) and Infectious Diseases (27 citations). Junaid Raja has collaborated with scholars based in United States, Germany and South Korea. Frequent co-authors include Hyun S. Kim, Johannes Ludwig, Scott Gettinger, Kurt A. Schalper, Amir M. Mohareb, Adebowale Adeniran, Junjian Huang, Mahan Mathur, Andrew Rennie and Monica Srodon. Their work appears in journals such as Journal for ImmunoTherapy of Cancer, World Medical & Health Policy, Journal of Infection and Public Health, Thrombosis Research and Abdominal Radiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.